Astellas Pharma Inc., of Tokyo, appointed Shontelle Dodson vice president, medical excellence, medical affairs. Dodson will be based at the global headquarters for the company's medical and development functions in Northbrook, Ill. Read More

SHANGHAI – Increasingly, Chinese biotechs are finding the time is right to take their pipelines to the U.S., and Sihuan Pharmaceutical Holdings Group Ltd., China's fourth largest pharma company (in hospital sales), is the latest to take the leap. Read More

NEW DELHI – India is taking a series of steps to power its biopharmaceutical industry that could lead to more investment, better infrastructure for drug development and a visible reduction in red tape. One of the more significant such steps is the development of a series of biotech and pharmaceutical industry clusters that could help speed up drug discovery and development. Read More

HONG KONG – A Sino-U.S. research collaboration has determined the atomic structure of the G protein-coupled (GPC) P2Y1 receptor, which plays a key role in thrombus formation, challenging conventional concepts of drug action at GPC receptors and opening the door for future new drug discovery and development. Read More

HONG KONG – In another blow to the operations of multinational pharmaceutical companies in China, Pfizer Inc. may have to suspend its vaccine business temporarily as it shifts from Prevenar 7 to Prevenar 13. Read More

Wuxi Pharmatech (Cayman) Inc., of Shanghai, said its wholly owned subsidiary, Syntheall Pharmaceutical Co. Ltd. (STA), received approval from China's National Equities Exchange and Quotations to list its shares on the New Third Board, China's over-the-counter stock exchange, beginning April 3. Read More